Krieg T - Search Results

1

Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.

Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Jerjen R, et al. Among authors: krieg t. J Am Acad Dermatol. 2022 Nov;87(5):937-954. doi: 10.1016/j.jaad.2021.10.065. Epub 2022 Feb 4. J Am Acad Dermatol. 2022. PMID: 35131402 Review.

2

Increased adhesion of fibroblasts from patients with scleroderma to extracellular matrix components: in vitro modulation by IFN-gamma but not by TGF-beta.

Majewski S, Hunzelmann N, Schirren CG, Mauch C, Aumailley M, Krieg T. Majewski S, et al. Among authors: krieg t. J Invest Dermatol. 1992 Jan;98(1):86-91. doi: 10.1111/1523-1747.ep12495664. J Invest Dermatol. 1992. PMID: 1728642 Free article.

3

Clinical association of autoantibodies to fibrillarin with diffuse scleroderma and disseminated telangiectasia.

Kurzhals G, Meurer M, Krieg T, Reimer G. Kurzhals G, et al. Among authors: krieg t. J Am Acad Dermatol. 1990 Nov;23(5 Pt 1):832-6. doi: 10.1016/0190-9622(90)70298-v. J Am Acad Dermatol. 1990. PMID: 2254467

4

Systemic scleroderma. Clinical and pathophysiologic aspects.

Krieg T, Meurer M. Krieg T, et al. J Am Acad Dermatol. 1988 Mar;18(3):457-81. doi: 10.1016/s0190-9622(88)70070-5. J Am Acad Dermatol. 1988. PMID: 3280619 Review.

5

The fibroblast in systemic sclerosis.

Sollberg S, Mauch C, Eckes B, Krieg T. Sollberg S, et al. Among authors: krieg t. Clin Dermatol. 1994 Jul-Sep;12(3):379-85. doi: 10.1016/0738-081x(94)90290-9. Clin Dermatol. 1994. PMID: 7954196 Review. No abstract available.

6

Control of fibrosis in systemic scleroderma.

Mauch C, Eckes B, Hunzelmann N, Oono T, Kozlowska E, Krieg T. Mauch C, et al. Among authors: krieg t. J Invest Dermatol. 1993 Jan;100(1):92S-96S. doi: 10.1111/1523-1747.ep12356293. J Invest Dermatol. 1993. PMID: 8423407 Free article. Review.

7

Decreased expression of alpha 2 beta 1 integrin in scleroderma fibroblasts.

Kozlowska E, Sollberg S, Mauch C, Eckes B, Klein CE, Krieg T. Kozlowska E, et al. Among authors: krieg t. Exp Dermatol. 1996 Feb;5(1):57-63. doi: 10.1111/j.1600-0625.1996.tb00094.x. Exp Dermatol. 1996. PMID: 8624613

8

Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma.

Hunzelmann N, Anders S, Fierlbeck G, Hein R, Herrmann K, Albrecht M, Bell S, Muche R, Wehner-Caroli J, Gaus W, Krieg T. Hunzelmann N, et al. Among authors: krieg t. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):433-5. doi: 10.1016/s0190-9622(97)80221-6. J Am Acad Dermatol. 1997. PMID: 9091475 Clinical Trial.

9

Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.

Hunzelmann N, Anders S, Fierlbeck G, Hein R, Herrmann K, Albrecht M, Bell S, Thur J, Muche R, Adelmann-Grill B, Wehner-Caroli J, Gaus W, Krieg T. Hunzelmann N, et al. Among authors: krieg t. Arch Dermatol. 1997 May;133(5):609-13. doi: 10.1001/archderm.133.5.609. Arch Dermatol. 1997. PMID: 9158414 Clinical Trial.

10

Bath-PUVA therapy in three patients with scleredema adultorum.

Hager CM, Sobhi HA, Hunzelmann N, Wickenhauser C, Scharenberg R, Krieg T, Scharffetter-Kochanek K. Hager CM, et al. Among authors: krieg t. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):240-2. doi: 10.1016/s0190-9622(98)70244-0. J Am Acad Dermatol. 1998. PMID: 9486680

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters